CHG-2022-0263

Container Closure Change for Upadacitimab. Specification Change for Upadacitimab — routine update. Impacts 7 markets and 4 variations.

Change Number
CHG-2022-0263
Type
Container Closure Change
Product
Upadacitimab
Status
Approved
Owner
Carlos Mendez
Initiated
2022-01-08
Description

Specification Change for Upadacitimab — routine update

Impacted Markets (7)
US — United StatesEU — European UnionFR — FranceNL — NetherlandsTW — TaiwanSE — SwedenBE — Belgium
Impacted Modules
3.2.S3.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved